Multifunctional roles of MT1-MMP in myofiber formation and morphostatic maintenance of skeletal muscle

被引:98
作者
Ohtake, Yohei
Tojo, Hideaki
Seiki, Motoharu
机构
[1] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan
[2] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Appl Genet, Tokyo 1138675, Japan
关键词
MT1-MMP; ECM remodeling; myogenesis; myopathy;
D O I
10.1242/jcs.03158
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Sequential activation of muscle-specific transcription factors is the critical basis for myogenic differentiation. However, the complexity of this process does not exclude the possibility that other molecules and systems are regulatory as well. We observed that myogenic differentiation proceeded through three distinct stages of proliferation, elongation and fusion, which are distinguishable by their cellular morphologies and gene expression patterns of proliferation- and differentiation-specific markers. Treatment of the differentiating myoblasts with inhibitors of matrix metalloproteinases (MMPs) revealed that MMP activity at the elongation stage is a critical prerequisite to complete the successive myoblast cell fusion. The MMP regulated the myogenic differentiation independently from the genetic program that governs expression of the myogenic genes. Membrane-type 1 matrix metalloproteinase (MT1-MMP) was identified as a major contributor to this checkpoint for morphological differentiation and degraded fibronectin, a possible inhibitory factor for myogenic cell fusion. A MT1-MMP deficiency caused similar myogenic impediments forming smaller myofibers in situ. Additionally, the mutant mice demonstrated some central nucleation of the myofibers typically found in muscular dystrophy and MT1-MMP was found to cleave laminin-2/4 in the basement membrane. Thus, MT1-MMP is a new multilateral regulator for muscle differentiation and maintenance through processing of stage-specific distinct ECM substrates.
引用
收藏
页码:3822 / 3832
页数:11
相关论文
共 42 条
[1]  
Akimov SS, 2001, J CELL SCI, V114, P2989
[2]   Metalloproteinase inhibitors: biological actions and therapeutic opportunities [J].
Baker, AH ;
Edwards, DR ;
Murphy, G .
JOURNAL OF CELL SCIENCE, 2002, 115 (19) :3719-3727
[3]   Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion [J].
Belkin, AM ;
Akimov, SS ;
Zaritskaya, LS ;
Ratnikov, BI ;
Deryugina, EI ;
Strongin, AY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :18415-18422
[4]   A SATELLITE CELL MITOGEN FROM CRUSHED ADULT MUSCLE [J].
BISCHOFF, R .
DEVELOPMENTAL BIOLOGY, 1986, 115 (01) :140-147
[5]  
CHAKRABORTY T, 1991, J BIOL CHEM, V266, P2878
[6]   ALTERATION IN CELL-SURFACE LETS PROTEIN DURING MYOGENESIS [J].
CHEN, LB .
CELL, 1977, 10 (03) :393-400
[7]  
Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO
[8]  
2-T
[9]  
Cooper RN, 1999, J CELL SCI, V112, P2895
[10]   RAT MYOBLAST FUSION REQUIRES METALLOENDOPROTEASE ACTIVITY [J].
COUCH, CB ;
STRITTMATTER, WJ .
CELL, 1983, 32 (01) :257-265